This website uses cookies to ensure you get the best experience on our website.

PolyPeptide Group and selected partners use cookies and similar technologies to ensure you get the best experience on this website. If you consent to it, we will use cookies for analytics purposes.

See our Cookie Policy to read more about the cookies we set.

You can withdraw and manage your consent at any time, by clicking "Manage cookies" at the bottom of each website page.

Select which cookies you accept

On this site, we always set cookies that are strictly necessary, meaning they are necessary for the site to function properly.

If you consent to it, we will also set other types of cookies. You can provide or withdraw your consent to the different types of cookies using the toggles below. You can change or withdraw your consent at any time, by clicking the link “Manage Cookies”, which is always available at the bottom of the site.

To learn more about what the different types of cookies do, how your data is used when they are set etc, see our Cookie Policy.

These cookies are necessary to make the site work properly, and are always set when you visit the site.

Vendors Teamtailor

These cookies collect information to help us understand how the site is being used.

Vendors Teamtailor
PolyPeptide Group career site

Braine-l'Alleud

Nos Valeurs

INNOVATION
- Nous sommes curieux et explorons de nouvelles voies
- Nous sommes ambitieux et trouvons des solutions

EXCELLENCE
- Nous avons une solide connaissance technique et nous obtenons des résultats
- Nous agissons avec qualité dans tout ce que nous faisons
- Nous sommes adaptables et orientés client

CONFIANCE
- Nous croyons au travail d'équipe et à la collaboration
- Nous donnons l'exemple et acceptons la responsabilité
- Nous sommes transparents et nous faisons preuve d'intégrité

Braine-l'Alleud

About PolyPeptide Group


PolyPeptide Group AG and its consolidated subsidiaries (“PolyPeptide”) is a focused Contract Development & Manufacturing Organization (CDMO) for peptide- and oligonucleotide-based active pharmaceutical ingredients. By supporting its customers mainly in pharma and biotech, it contributes to the health of millions of patients across the world.

PolyPeptide offers products and services from pre-clinical through to commercial stages, including generics. Its active custom projects pipeline reflects the opportunities from novel drug therapies in development to fight both widespread and rare diseases. Dating back to 1952, PolyPeptide today runs a global network of six cGMP-certified facilities in Europe, the U.S. and India. PolyPeptide Group AG’s shares (SIX: PPGN) are listed on SIX Swiss Exchange.

Founded in 1996
Co-workers Around 1,200